UMC | Uppsala Monitoring Centre

Working for a better world

In our role as a WHO Collaborating Centre, we provide training, guidance and support to countries in the WHO Programme for International Drug Monitoring. We also manage VigiBase, WHO’s database of individual case safety reports and the world’s largest repository of adverse effects from medicines.

Click on our interactive map for more information on members of the WHO programme

[{data: [
{"iso-a2":"AF",value:2016,color:"#003763",category:"Full Member", links:[{name:"National Medicine and Healthcare Products Regulatory Authority",link:"https://nmhra.gov.af/"}]},
{"iso-a2":"AE",value:2013,color:"#003763",category:"Full Member", links:[{name:"United Arab Emirates, Ministry of Health",link:"http://www.mohap.gov.ae/en/Pages/default.aspx"}]},
{"iso-a2":"AL",value:2020,color:"#003763",category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"http://www.akbpm.gov.al"}]},
{"iso-a2":"AD",value:2008,color:"#003763",category:"Full Member", links:[{name:"Service of Pharmacy",link:"http://www.salut.ad/"}]},
{"iso-a2":"AO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direccao Nacional de Medicamentos e Equipamentos",link:"dnme.co.ao"}]},
{"iso-a2":"AI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Princess Alexandra Hospital",link:"http://www.paho.org"}]},
{"iso-a2":"AG",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Mount St. John's Medical Centre",link:"http://www.paho.org"}]},
{"iso-a2":"AR",value:1994,color:"#003763",category:"Full Member", links:[{name:"Administración Nacional de Medicamentos, Alimentos y Tecnología Médica",link:"http://www.anmat.gov.ar/farmacovigilancia/principal.asp"}]},
{"iso-a2":"AM",value:2001,color:"#003763",category:"Full Member", links:[{name:"Scientific Centre of Drug and Medical Technology Expertise",link:"http://pharm.am/index.php/en/drug-safety-profile "}]},
{"iso-a2":"AU",value:1968,color:"#003763",category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]},
{"iso-a2":"AT",value:1991,color:"#003763",category:"Full Member", links:[{name:"Austrian Agency for Health and Food Safety",link:"http://www.basg.gv.at/ www.ages.at"}]},
{"iso-a2":"AZ",value:2018,color:"#003763",category:"Full Member", links:[{name:"Analytical Expertise Center",link:"http://pharma.az/"}]},
{"iso-a2":"BH",value:2002,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy and Drug Control",link:"http://www.moh.gov.bh/"}]},
{"iso-a2":"BD",value:2014,color:"#003763",category:"Full Member", links:[{name:"Directorate General of Drug Administration",link:"http://www.dgda.gov.bd/index.php/2013-03-31-04-35-57/adrm-reaction-monitoring"}]},
{"iso-a2":"BB",value:2008,color:"#003763",category:"Full Member", links:[{name:"Barbados Drug Service",link:"http://drugservice.health.gov.bb/"}]},
{"iso-a2":"BY",value:2006,color:"#003763",category:"Full Member", links:[{name:"Center for Examinations and Testing in Health Service",link:"http://rceth.by/ru/Safety"}]},
{"iso-a2":"BZ",value:2020,color:"#009ABE",category:"Associate Member", links:[{name:"Pharmacy Department of the Ministry of Health",link:"http://www.health.gov.bz/www/units/pharmacy"}]},

{"iso-a2":"BE",value:1977,color:"#003763",category:"Full Member", links:[{name:"Federal Agency for Medicines and Health Products",link:"http://www.basg.gv.at/en/basg-austrian-federal-office-for-safety-in-health-care/"}]},
{"iso-a2":"BJ",value:2011,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies et du Médicament",link:"http://www.beninsante.bj"}]},
{"iso-a2":"BT",value:2014,color:"#003763",category:"Full Member", links:[{name:"National Pharmacovigilance Centre",link:"http://dra.gov.bt/"}]},
{"iso-a2":"BO",value:2013,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.minsalud.gob.bo/"}]},
{"iso-a2":"BA",value:2019,color:"#003763",category:"Full Member", links:[{name:"Agency for Medicines and Medical Devices of Bosnia and Herze",link:"http://www.almbih.gov.ba/"}]},
{"iso-a2":"BW",value:2009,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Unit",link:"http://www.moh.gov.bw/"}]},
{"iso-a2":"BR",value:2001,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Vigilanica Sanitaria",link:"http://portal.anvisa.gov.br/farmacovigilancia"},{name:"Universidade de Sao Paulo",link:"Not applicable"}]},
{"iso-a2":"BN",value:2005,color:"#003763",category:"Full Member", links:[{name:"National Adverse Drug Reaction Monitoring Centre",link:"http://www.moh.gov.bn/SitePages/Pharmacy%20Overview.aspx"}]},
{"iso-a2":"BG",value:1975,color:"#003763",category:"Full Member", links:[{name:"Bulgarian Drug Agency",link:"http://www.bda.bg"}]},
{"iso-a2":"BF",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction Generale de la Pharmacie (DGPML)",link:"http://www.dgpml.sante.gov.bf"}]},
{"iso-a2":"BI",value:2010,color:"#009ABE",category:"Associate Member", links:[{name:"Direction de la Pharmacie, du Médicament et des Laboratoires",link:""}]},
{"iso-a2":"CM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament",link:""}]},
{"iso-a2":"CA",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Canada",link:"http://www.hc-sc.gc.ca"},{name:"Vaccine Preventable Diseases & Vaccine Safety",link:"http://www.phac-aspc.gc.ca"}]},
{"iso-a2":"CV",value:2012,color:"#003763",category:"Full Member", links:[{name:"Agência de Regulacâo e Supervisâo dos Produtos Farmacêuticos",link:"http://www.arfa.cv/index.php/setor-farmaceutico/farmacovigilancia"}]},
{"iso-a2":"CL",value:1996,color:"#003763",category:"Full Member", links:[{name:"Instituto de Salud Publica de Chile",link:"http://www.ispch.cl/anamed_/farmacovigilancia"}]},
{"iso-a2":"CN",value:1998,color:"#003763",category:"Full Member", links:[{name:"China Food and Drug Administration",link:"http://english.nmpa.gov.cn/index.html"}]},
{"iso-a2":"CO",value:2004,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Vigilancia de Medicamentos y Alimentos",link:"https://www.invima.gov.co/index.php?option=com_content&view=article&id=764:farmacovigilancia&catid=191:farmacovigilancia&Itemid=323"}]},

{"iso-a2":"CG",value:2020,color:"#009ABE",category:"Associate Member", links:[{name:"Ministère de la Santé",link:""}]},

{"iso-a2":"CD",value:2010,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance",link:""}]},
{"iso-a2":"CR",value:1991,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.ministeriodesalud.go.cr/index.php/regulacion-de-la-salud/farmacovigilancia"}]},
{"iso-a2":"CI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Autorité Ivoirienne de Régulation Pharmaceutique (AIRP)",link:""}]},
{"iso-a2":"CU",value:1994,color:"#003763",category:"Full Member", links:[{name:"Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos",link:"https://www.cecmed.cu/vigilancia"}]},
{"iso-a2":"CY",value:2000,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Services",link:"http://www.moh.gov.cy/moh/phs/phs.nsf/dmlindex_en/dmlindex_en?opendocument"}]},
{"iso-a2":"CZ",value:1992,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Czech Republic",link:"http://www.sukl.eu/index.php?lang=2"}]},
{"iso-a2":"CH",value:1991,color:"#003763",category:"Full Member", links:[{name:"Swissmedic",link:"https://www.swissmedic.ch/swissmedic/de/home.html"}]},
{"iso-a2":"DE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Federal Institute for Drugs and Medical Devices",link:"http://www.bfarm.de/cln_012/nn_424276/EN"},{name:"Paul Ehrlich Institut",link:"http://www.pei.de/EN/home/node.html"}]},
{"iso-a2":"DZ",value:2021,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance et de Materiovigilance",link:"http://www.cnpm.org.dz"}]},
{"iso-a2":"DK",value:1971,color:"#003763",category:"Full Member", links:[{name:"Danish Medicines Agency",link:"http://laegemiddelstyrelsen.dk/en"}]},
{"iso-a2":"DM",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Grand Health Center",link:"http://www.paho.org"}]},
{"iso-a2":"DO",value:2020,color:"#003763",category:"Full Member", links:[{name:"Ministry of Public Health",link:"http://iddi.org/es/salud/"}]},
{"iso-a2":"EC",value:2017,color:"#003763",category:"Full Member", links:[{name:"Agencia Nacional de Regulación, Control y Vigilancia Sanitaria",link:"http://www.controlsanitario.gob.ec"}]},
{"iso-a2":"ES",value:1984,color:"#003763",category:"Full Member", links:[{name:"Spanish Agency for Medicines and Healthcare Products",link:"https://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/home.htm"}]},
{"iso-a2":"ET",value:2008,color:"#003763",category:"Full Member", links:[{name:"Food & Drug Authority",link:"http://www.fmhaca.gov.et/pharmacovigilance.html"}]},
{"iso-a2":"ER",value:2012,color:"#003763",category:"Full Member", links:[{name:"Eritrean National Pharmacovigilance Centre",link:"http://pveritrea.com/"}]},
{"iso-a2":"EE",value:1998,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines",link:"http://www.ravimiamet.ee/en"}]},
{"iso-a2":"EG",value:2001,color:"#003763",category:"Full Member", links:[{name:"Egyptian Pharmaceutical Vigilance Center",link:"http://www.epvc.gov.eg/"}]},
{"iso-a2":"FJ",value:1999,color:"#003763",category:"Full Member", links:[{name:"Fiji Pharmaceutical & Biomedical Services Centre",link:"http://www.health.gov.fj"}]},
{"iso-a2":"FI",value:1974,color:"#003763",category:"Full Member", links:[{name:"Finnish Medicines Agency",link:"http://www.fimea.fi/web/en/pharmaceutical_safety_and_information"}]},
{"iso-a2":"FR",value:1986,color:"#003763",category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]},
{"iso-a2":"GM",value:2011,color:"#009ABE",category:"Associate Member", links:[{name:"Medicines Control Agency",link:""}]},
{"iso-a2":"GE",value:2018,color:"#003763",category:"Full Member", links:[{name:"Lepl Regulatory Agency for Medical and Pharmaceutical Activities",link:"http://moh.gov.ge"}]},
{"iso-a2":"GH",value:2001,color:"#003763",category:"Full Member", links:[{name:"Food and Drugs Authority",link:"http://www.fdaghana.gov.gh"}]},
{"iso-a2":"GR",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Organization for Medicines",link:"http://www.eof.gr/web/guest/home"}]},
{"iso-a2":"GD",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Central Medical Stores, Grenada",link:"http://www.paho.org"}]},
{"iso-a2":"GT",value:2002,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud Publica y Asistencia Social",link:"http://www.mspas.gob.gt/index.php/en/servicios/farmacovigilancia.html"}]},
{"iso-a2":"GN",value:2013,color:"#003763",category:"Full Member", links:[{name:"Direction Nationale de la Pharmacie et des Laboratoires",link:""}]},
{"iso-a2":"GY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http://www.health.gov.gy"}]},
{"iso-a2":"GW",value:2009,color:"#009ABE",category:"Associate Member", links:[{name:"Guinée-Bissau Ministério da Saúde",link:""}]},
{"iso-a2":"GB",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]},
{"iso-a2":"HR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Croatian Agency for Medicinal Products and Devices",link:"http://www.halmed.hr/en/"}]},
{"iso-a2":"HN",value:2020,color:"#003763",category:"Full Member", links:[{name:"Agencia de Regulación Sanitaria",link:"http://www.arsa.gob.hn/"}]},
{"iso-a2":"HU",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Institute of Pharmacy and Nutrion",link:"https://www.ogyei.gov.hu/pharmacovigilance/"}]},
{"iso-a2":"HT",value:2016,color:"#009ABE",category:"Associate Member", links:[{name:"Ministère de la Santé Publique et de la Population",link:"http://mspp.gouv.ht/newsite/"}]},
{"iso-a2":"IS",value:1990,color:"#003763",category:"Full Member", links:[{name:"Icelandic Medicines Agency",link:"http://www.ima.is/Pharmacovigilance/"}]},
{"iso-a2":"IN",value:1998,color:"#003763",category:"Full Member", links:[{name:"Indian Pharmacopoeia Commission",link:"http://www.ipc.gov.in"}]},
{"iso-a2":"ID",value:1975,color:"#003763",category:"Full Member", links:[{name:"Indonesia National Agency of Drug and Food Control",link:"http://www.pom.go.id/new/index.php/home/en"}]},
{"iso-a2":"IR",value:1998,color:"#003763",category:"Full Member", links:[{name:"Iranian Adverse Drug Reaction Monitoring Centre",link:"http://www.mohme.gov.ir"}]},
{"iso-a2":"IQ",value:2010,color:"#003763",category:"Full Member", links:[{name:"Iraqi Pharmacovigilance Center",link:"http://www.mohiraq.org"}]},
{"iso-a2":"IE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Health Products Regulatory Authority",link:"http://www.hpra.ie/homepage/medicines"}]},
{"iso-a2":"IL",value:1973,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Information and Risk Management",link:"http://www.health.gov.il/English/MinistryUnits/HealthDivision/MedicalTechnologies/Drugs/risk/Pages/default.aspx"}]},
{"iso-a2":"IT",value:1975,color:"#003763",category:"Full Member", links:[{name:"Agenzia Italiana del Farmaco",link:"http://www.agenziafarmaco.gov.it/en/content/post-marketing-surveillance"}]},
{"iso-a2":"JM",value:2012,color:"#003763",category:"Full Member", links:[{name:"Pharmwatch Jamaica",link:"http://www.moh.gov.jm"}]},
{"iso-a2":"JP",value:1972,color:"#003763",category:"Full Member", links:[{name:"Pharmaceuticals and Medical Devices Agency",link:"http://www.pmda.go.jp/english/index.html"}]},
{"iso-a2":"JO",value:2002,color:"#003763",category:"Full Member", links:[{name:"Jordan Food and Drug Administration",link:"http://www.jfda.jo"}]},
{"iso-a2":"KH",value:2012,color:"#003763",category:"Full Member", links:[{name:"Cambodian Pharmacovigilance Center",link:"http://www.ddfcambodia.com"}]},
{"iso-a2":"KZ",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Center for Expertise of medicines, medical devices and medical equipment - NCEMMD",link:"http://www.ndda.kz "}]},
{"iso-a2":"KE",value:2010,color:"#003763",category:"Full Member", links:[{name:"Pharmacy and Poisons Board",link:"http://www.pharmacyboardkenya.org"}]},
{"iso-a2":"KR",value:1992,color:"#003763",category:"Full Member", links:[{name:"Ministry of Food and Drug Safety",link:" http://www.mfds.go.kr/eng/index.do"}]},
{"iso-a2":"KG",value:2003,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Provision & Medical Equipment",link:"http://pharm.kg/ru/farmakonadzor/ "}]},
{"iso-a2":"KN",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health, St. Kitts and Nevis",link:"http://www.paho.org"}]},
{"iso-a2":"KW",value:2021,color:"#003763",category:"Full Member", links:[]},
{"iso-a2":"LA",value:2015,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Department, Ministry of Health",link:"http://www.fdd.gov.la"}]},
{"iso-a2":"LB",value:2021,color:"#003763",category:"Full Member", links:[{name:"Ministry of Public Health",link:"https://www.moph.gov.lb/en/Pages/4/44742/pharmacovigilance-system-lebanon"}]},
{"iso-a2":"LV",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Agency of Medicines of Latvia",link:"https://www.zva.gov.lv//?id=420&sa=420&top=386"}]},
{"iso-a2":"LR",value:2013,color:"#003763",category:"Full Member", links:[{name:"Liberia Medicines and Health Products Regulatory Authority",link:"http://www.lmhralib.org/departments/pharmacovigilance/"}]},
{"iso-a2":"LT",value:2005,color:"#003763",category:"Full Member", links:[{name:"State Medicines Control Agency",link:"http://www.vvkt.lt/Pharmacovigilance"}]},
{"iso-a2":"LC",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"OECS - Pharmaceutical Procurement Service",link:"http://www.oecs.org/"},{name:"Ministry of Health, St Lucia",link:"http://www.paho.org"}]},
{"iso-a2":"LK",value:2000,color:"#003763",category:"Full Member", links:[{name:"National Medicines Regulatory Authority",link:"http://nmra.gov.lk/index.php?lang=en"}]},

{"iso-a2":"LU",value:2020,color:"#003763",category:"Full Member", links:[{name:"Division of Pharmacy and Medicines of the National Health Directorate",link:"https://guichet.public.lu/en/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html"}]},

{"iso-a2":"LY",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health",link:"http://www.health.gov.ly/"}]},
{"iso-a2":"MK",value:2000,color:"#003763",category:"Full Member", links:[{name:"North Macedonian Agency for medicines and medical devices",link:"https://malmed.gov.mk/"}]},
{"iso-a2":"MG",value:2009,color:"#003763",category:"Full Member", links:[{name:"Agence du Médicament de Madagascar",link:"http://www.sante.gov.mg"}]},
{"iso-a2":"MW",value:2019,color:"#003763",category:"Full Member", links:[{name:"Pharmacy, Medicines and Poisons Board",link:"http://www.health.gov.mw "}]},
{"iso-a2":"MY",value:1990,color:"#003763",category:"Full Member", links:[{name:"National Pharmaceutical Control Bureau",link:"http://npra.moh.gov.my"}]},
{"iso-a2":"MV",value:2016,color:"#003763",category:"Full Member", links:[{name:"Maldives Food and Drug Authority",link:"http://www.mfda.gov.mv/English/index.php"}]},
{"iso-a2":"ML",value:2011,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Mali",link:""}]},
{"iso-a2":"MM",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Department of Food and Drug Administration, Ministry of Health and Sports",link:"http://www.fdamyanmar.gov.mm/"}]},
{"iso-a2":"MT",value:2004,color:"#003763",category:"Full Member", links:[{name:"Malta Medicines Authority",link:"http://www.medicinesauthority.gov.mt"}]},
{"iso-a2":"MU",value:2014,color:"#003763",category:"Full Member", links:[{name:"National PV centre of Mauritius",link:""}]},
{"iso-a2":"MX",value:1999,color:"#003763",category:"Full Member", links:[{name:"Federal Commission for the Protection against Sanitary Risk",link:"http://www.cofepris.gob.mx/AZ/Paginas/Farmacovigilancia/Farmacovigilancia.aspx"}]},
{"iso-a2":"MD",value:2003,color:"#003763",category:"Full Member", links:[{name:"Medicines Agency",link:"http://amed.md/en/content/pharmacovigilance "}]},
{"iso-a2":"MN",value:2005,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulation Division, Center for Health Development",link:""}]},
{"iso-a2":"ME",value:2009,color:"#003763",category:"Full Member", links:[{name:"Institute for Medicines and Medical Devices of Montenegro",link:"http://www.mzd.gov.me"}]},
{"iso-a2":"MS",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Glendon Hospital Pharmacy",link:"http://www.paho.org"}]},
{"iso-a2":"MA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Centre Anti Poison et de Pharmacovigilance",link:"http://rcc-pv.ma/"}]},
{"iso-a2":"MZ",value:2005,color:"#003763",category:"Full Member", links:[{name:"Pharmaceutical Department",link:"http://www.misau.gov.mz/index.php"}]},
{"iso-a2":"NA",value:2008,color:"#003763",category:"Full Member", links:[{name:"Namibia Medicines Regulatory Council",link:"http://www.nmrc.com.na/tipc"}]},
{"iso-a2":"NP",value:2006,color:"#003763",category:"Full Member", links:[{name:"Department of Drug Administration",link:"http://www.dda.gov.np"}]},
{"iso-a2":"NI",value:2020,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud de Nicaragua",link:"http://www.minsa.gob.ni/"}]},
{"iso-a2":"NL",value:1968,color:"#003763",category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]},
{"iso-a2":"NZ",value:1968,color:"#003763",category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]},
{"iso-a2":"NE",value:2012,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie, des Laboratoires et de la Médecin",link:""}]},
{"iso-a2":"NG",value:2004,color:"#003763",category:"Full Member", links:[{name:"National Agency for Food and Drug Administration and Control",link:"http://www.nafdac.gov.ng/index.php/about-nafdac/faqs/pharmacovigilance"}]},
{"iso-a2":"NO",value:1971,color:"#003763",category:"Full Member", links:[{name:"Norwegian Medicines Agency",link:"https://legemiddelverket.no/English"}]},
{"iso-a2":"OM",value:1995,color:"#003763",category:"Full Member", links:[{name:"Directorate General Pharmaceutical Affairs and Drug Control",link:"https://www.moh.gov.om/en_US/web/dgpadc"}]},
{"iso-a2":"PK",value:1994,color:"#009ABE",category:"Associate Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk"}]},
{"iso-a2":"PA",value:2005,color:"#003763",category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.minsa.gob.pa/informacion-salud/centro-nacional-de-farmacovigilancia"}]},
{"iso-a2":"PG",value:2018,color:"#003763",category:"Full Member", links:[{name:"Papua New Guinea Drug Information and Pharmacovigilance Unit",link:"http://www.health.gov.pg"}]},
{"iso-a2":"PE",value:2002,color:"#003763",category:"Full Member", links:[{name:"Direccion General de Medicamentos, Insumos y Drogas",link:"http://www.digemid.minsa.gob.pe/main.asp?Seccion=572"}]},
{"iso-a2":"PH",value:1995,color:"#003763",category:"Full Member", links:[{name:"Food and Drug Administration",link:"http://www.fda.gov.ph"}]},
{"iso-a2":"PK",value:2018,color:"#003763",category:"Full Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk/"}]},
{"iso-a2":"PL",value:1972,color:"#003763",category:"Full Member", links:[{name:"Office for Registration of Medicinal Products, URPL",link:"http://www.urpl.gov.pl/en"}]},
{"iso-a2":"PT",value:1993,color:"#003763",category:"Full Member", links:[{name:"INFARMED",link:"http://www.infarmed.pt/web/infarmed/entidades/medicamentos-uso-humano/farmacovigilancia"}]},
{"iso-a2":"PY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Dirección Nacional de Vigilancia Sanitaria",link:"https://www.mspbs.gov.py/dnvs"}]},
{"iso-a2":"QA",value:2013,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Council of Health",link:"https://www.moph.gov.qa/home-en"}]},
{"iso-a2":"RO",value:1976,color:"#003763",category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"http://www.anm.ro/anmdm/en/index.html"}]},
{"iso-a2":"RU",value:1998,color:"#003763",category:"Full Member", links:[{name:"Federal Service on Surveillance in Healthcare and Soc.Dev",link:"http://www.roszdravnadzor.ru/drugs/monitpringlp "}]},
{"iso-a2":"RW",value:2013,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Task Force, Ministry of Health",link:"http://www.moh.gov.rw"}]},
{"iso-a2":"RS",value:2000,color:"#003763",category:"Full Member", links:[{name:"Medicines and Medical Devices Agency of Serbia",link:"http://www.alims.gov.rs"}]},
{"iso-a2":"SV",value:2017,color:"#003763",category:"Full Member", links:[{name:"Ministerio de Salud",link:"http://www.salud.gob.sv"}]},
{"iso-a2":"SA",value:2009,color:"#003763",category:"Full Member", links:[{name:"Saudi Food and Drug Authority",link:"http://www.sfda.gov.sa/EN/DRUG/ABOUT/SECTOR_DEPARTMENTS/NATIONAL_PHARMACOVIGILANCE_CENTER/Pages/default.aspx"}]},
{"iso-a2":"SS",value:2018,color:"#009ABE",category:"Associate Member",links:[{name:"",link:""}]},
{"iso-a2":"SN",value:2009,color:"#003763",category:"Full Member", links:[{name:"Direction de la Pharmacie et des Laboratoires",link:"http://www.sante.gouv.sn"}]},
{"iso-a2":"SL",value:2008,color:"#003763",category:"Full Member", links:[{name:"Pharmacy Board of Sierra Leone",link:"http://www.pharmacyboard.gov.sl"}]},
{"iso-a2":"SG",value:1993,color:"#003763",category:"Full Member", links:[{name:"Health Sciences Authority",link:"http://www.hsa.gov.sg"}]},
{"iso-a2":"SK",value:1993,color:"#003763",category:"Full Member", links:[{name:"State Institute for Drug Control, Slovakia",link:"http://www.sukl.sk/en/drug-safety/scope-of-activities?page_id=4020"}]},
{"iso-a2":"SI",value:2010,color:"#003763",category:"Full Member", links:[{name:"Agency for medicinal products and medical devices",link:"http://www.jazmp.si/en/"}]},
{"iso-a2":"SD",value:2008,color:"#003763",category:"Full Member", links:[{name:"National Medicines and Poisons Board",link:"http://www.nmpb.gov.sd/"}]},
{"iso-a2":"SR",value:2007,color:"#003763",category:"Full Member", links:[{name:"Office of Pharmacy Policy",link:""}]},
{"iso-a2":"SZ",value:2015,color:"#003763",category:"Full Member", links:[{name:"Eswatini Pharmacovigilance Centre - Central Medical Stores",link:"http://www.gov.sz/index.php?option=com_content&view=article&id=267&Itemid=403"}]},
{"iso-a2":"SE",value:1968,color:"#003763",category:"Full Member", links:[{name:"Medical Products Agency",link:"https://lakemedelsverket.se/english/"}]},
{"iso-a2":"SY",value:2018,color:"#003763",category:"Full Member", links:[{name:"Syrian Ministry of Health",link:"http://www.moh.gov.sy"}]},
{"iso-a2":"TD",value:2018,color:"#003763",category:"Full Member", links:[{name:"Bureau de Pharmacovigilance",link:"http://www.sante-tchad.org"}]},
{"iso-a2":"TZ",value:1993,color:"#003763",category:"Full Member", links:[{name:"Tanzania Food and Drugs Authority",link:"http://www.tfda.go.tz"}]},
{"iso-a2":"TH",value:1984,color:"#003763",category:"Full Member", links:[{name:"Thai Food and Drug Administration",link:"http://thaihpvc.fda.moph.go.th/thaihvc/index.jsf"}]},
{"iso-a2":"TG",value:2007,color:"#003763",category:"Full Member", links:[{name:"Direction des Pharmacies",link:"http://www.everyoneweb.fr/pharmacovigilance"}]},
{"iso-a2":"TL",value:2019,color:"#009ABE",category:"Associate Member", links:[{name:"Ministry of Health",link:"http://moh.gov.tl/"}]},
{"iso-a2":"TN",value:1993,color:"#003763",category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Tunisia",link:""}]},
{"iso-a2":"TR",value:1987,color:"#003763",category:"Full Member", links:[{name:"Turkish Pharmacovigilance Center",link:"http://www.titck.gov.tr"}]},
{"iso-a2":"TJ",value:2015,color:"#009ABE",category:"Associate Member", links:[{name:"Office of National Supervision for Pharmaceutical Activities",link:"http://www.pharmnadzor.tj/index.html"}]},
{"iso-a2":"UG",value:2007,color:"#003763",category:"Full Member", links:[{name:"National Drug Authority",link:"http://www.nda.or.ug"}]},
{"iso-a2":"UA",value:2002,color:"#003763",category:"Full Member", links:[{name:"State Expert Center",link:"http://www.dec.gov.ua/index.php/ua/farmakonaglyad "}]},
{"iso-a2":"US",value:1968,color:"#003763",category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:"US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]},
{"iso-a2":"UY",value:2001,color:"#003763",category:"Full Member", links:[{name:"Department of Pharmaceuticals",link:"http://www.msp.gub.uy"}]},
{"iso-a2":"UZ",value:2006,color:"#003763",category:"Full Member", links:[{name:"Pharmacological Committee of HDDMEC",link:"http://uzpharm-control.uz/"}]},
{"iso-a2":"VC",value:2020,color:"#003763",category:"Full Member", links:[{name:"SVG Pharmacovigilance & Drug Information Centre",link:"http://www.paho.org"}]},
{"iso-a2":"VE",value:1995,color:"#003763",category:"Full Member", links:[{name:"Instituto Nacional de Higiene, Rafael Rangel",link:"http://www.inhrr.gob.ve/sistema_nacional_farmacovigilancia_ce.php"}]},
{"iso-a2":"VN",value:1999,color:"#003763",category:"Full Member", links:[{name:"National Centre of Drug Information & Adverse Drug Reactions",link:"http://canhgiacduoc.org.vn/en.aspx"}]},
{"iso-a2":"VI",value:2008,color:"#009ABE",category:"Associate Member", links:[{name:"Drugs & Pharmaceutical Services",link:"http://www.paho.org"}]},
{"iso-a2":"YE",value:2018,color:"#009ABE",category:"Associate Member", links:[{name:"Supreme Board of Drugs and Medical Appliances",link:"http://www.sbd-ye.org/"}]},
{"iso-a2":"ZA",value:1992,color:"#003763",category:"Full Member", links:[{name:"Medicines Regulatory Authority",link:"https://www.sahpra.org.za/"}]},
{"iso-a2":"Zanzi",value:2007,color:"#009ABE",category:"Associate Member", links:[{name:"Zanzibar Food and Drugs Board",link:"http://www.zfdb.go.tz"}]},
{"iso-a2":"ZM",value:2010,color:"#003763",category:"Full Member", links:[{name:"Zambia Medicines Regulatory Authority",link:"http://www.zamra.co.zm"}]},
{"iso-a2":"ZW",value:1998,color:"#003763",category:"Full Member", links:[{name:"Medicines Control Authority of Zimbabwe",link:"http://www.mcaz.co.zw"}]}],joinBy: 'iso-a2',name: 'Member status',mapData: Highcharts.maps['custom/world-palestine'],states: { hover: { color: '#a02741' }}}]

*This map is an approximation of actual country borders.

Making medicines safer for patients everywhere

WHODrug Koda

Find out how our AI coding engine can empower your team with UMC know-how and expertise

UMC Annual Report

July 2019-June 2020

Meet the new CEO

Hervé Le Louët took over
as CEO of UMC in November

Making medicines safer for patients

Protecting patients from harm

Leading the way in drug safety

WHODrug Global

Working for a better world

Making medicines safer for patients everywhere

WHODrug Koda

Find out how our AI coding engine can empower your team with UMC know-how and expertise

UMC Annual Report

July 2019-June 2020

Meet the new CEO

Hervé Le Louët took over as CEO of UMC in November

Making medicines safer for patients

Protecting patients from harm

Leading the way in drug safety

WHODrug Global

Working for a better world

Hervé Le Louët took over
as CEO of UMC in November